This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
CLN8 Antibody
catalog :
NBP1-91333
quantity :
100 ul (also 20 ul)
price :
329 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, dogs
application :
western blot
product information
SKU :
NBP1-91333
product name :
CLN8 Antibody
unit size :
100 ul (also 20 ul)
Description :
The CLN8 Antibody from Novus is a rabbit polyclonal antibody to CLN8. This antibody reacts with human, canine, equine, guinea pig. The CLN8 Antibody has been validated for the following applications: Western Blot.
target :
CLN8
category :
Primary Antibodies
buffer :
PBS and 2% Sucrose
clonality :
Polyclonal
conjugate :
Unconjugated
host :
Rabbit
immunogen :
MNPASDGGTSESIFDLDYASWGIRSTLMVAGFVFYLGVF
VVCHQLSSSLN.
Synthetic peptide directed towards the N terminal of human CLN8. Peptide sequence
VVCHQLSSSLN.
Synthetic peptide directed towards the N terminal of human CLN8. Peptide sequence
isotype :
IgG
purity :
Immunogen affinity purified
species :
Human, Canine, Equine, Guinea Pig
gene symbol :
CLN8
catalog number base :
NBP1-91333
accessionNumbers :
NP_061764
applications :
Western Blot
2020 Proposedprice USD :
329 USD
alt names :
C8orf61, ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation), EPMR
storage :
Store at -20C. Avoid freeze-thaw cycles.
company information

Novus Biologicals
8100 Southpark Way, A-8
Littleton, CO 80120
Littleton, CO 80120
novus@novusbio.com
https://www.novusbio.com3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.
questions and comments
